Gulyban A - Search Results

1

Interobserver variability in organ at risk delineation in head and neck cancer.

van der Veen J, Gulyban A, Willems S, Maes F, Nuyts S. van der Veen J, et al. Among authors: gulyban a. Radiat Oncol. 2021 Jun 28;16(1):120. doi: 10.1186/s13014-020-01677-2. Radiat Oncol. 2021. PMID: 34183040 Free PMC article.

2

Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.

Fairchild A, Langendijk JA, Nuyts S, Scrase C, Tomsej M, Schuring D, Gulyban A, Ghosh S, Weber DC, Budach W. Fairchild A, et al. Among authors: gulyban a. Radiat Oncol. 2014 Nov 26;9:248. doi: 10.1186/s13014-014-0248-9. Radiat Oncol. 2014. PMID: 25424399 Free PMC article. Clinical Trial.

3

Interobserver variability in delineation of target volumes in head and neck cancer.

van der Veen J, Gulyban A, Nuyts S. van der Veen J, et al. Among authors: gulyban a. Radiother Oncol. 2019 Aug;137:9-15. doi: 10.1016/j.radonc.2019.04.006. Epub 2019 Apr 29. Radiother Oncol. 2019. PMID: 31048235

4

Impact of consensus guidelines on delineation of primary tumor clinical target volume (CTVp) for head and neck cancer: Results of a national review project.

Bollen H, Gulyban A, Nuyts S. Bollen H, et al. Among authors: gulyban a. Radiother Oncol. 2023 Dec;189:109915. doi: 10.1016/j.radonc.2023.109915. Epub 2023 Sep 20. Radiother Oncol. 2023. PMID: 37739317 Free article.

5

Multisegmented tangential breast fields: a rational way to treat breast cancer.

Gulybán A, Kovács P, Sebestyén Z, Farkas R, Csere T, Karácsonyi G, Dérczy K, Hideghéty K, Esik O. Gulybán A, et al. Strahlenther Onkol. 2008 May;184(5):262-9. doi: 10.1007/s00066-008-1770-1. Strahlenther Onkol. 2008. PMID: 18427757

6

Triggered Imaging With Auto Beam Hold and Pre-/Posttreatment CBCT During Prostate SABR: Analysis of Time Efficiency, Target Coverage, and Normal Volume Changes.

Kisivan K, Antal G, Gulyban A, Glavak C, Laszlo Z, Kalincsak J, Gugyeras D, Jenei T, Csima M, Lakosi F. Kisivan K, et al. Among authors: gulyban a. Pract Radiat Oncol. 2021 Mar-Apr;11(2):e210-e218. doi: 10.1016/j.prro.2020.04.014. Epub 2020 May 23. Pract Radiat Oncol. 2021. PMID: 32454177

7

Improving generalization in MR-to-CT synthesis in radiotherapy by using an augmented cycle generative adversarial network with unpaired data.

Brou Boni KND, Klein J, Gulyban A, Reynaert N, Pasquier D. Brou Boni KND, et al. Among authors: gulyban a. Med Phys. 2021 Jun;48(6):3003-3010. doi: 10.1002/mp.14866. Epub 2021 Apr 24. Med Phys. 2021. PMID: 33772814

8

Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.

Dragan T, Duprez F, Van Gossum A, Gulyban A, Beauvois S, Digonnet A, Lalami Y, Van Gestel D. Dragan T, et al. Among authors: gulyban a. BMC Cancer. 2021 Jun 2;21(1):656. doi: 10.1186/s12885-021-08348-9. BMC Cancer. 2021. PMID: 34078309 Free PMC article.

9

Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.

Fenton PA, Hurkmans C, Gulyban A, van der Leer J, Matzinger O, Poortmans P, Collette L, Bolla M. Fenton PA, et al. Among authors: gulyban a. Radiother Oncol. 2013 Jun;107(3):346-51. doi: 10.1016/j.radonc.2013.04.020. Epub 2013 May 23. Radiother Oncol. 2013. PMID: 23707151

10

Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?

Berkovic P, Paelinck L, Lievens Y, Gulyban A, Goddeeris B, Derie C, Surmont V, De Neve W, Vandecasteele K. Berkovic P, et al. Among authors: gulyban a. Acta Oncol. 2015;54(9):1438-44. doi: 10.3109/0284186X.2015.1061209. Epub 2015 Sep 25. Acta Oncol. 2015. PMID: 26405809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters